Member Info for faceface

This should bring more interest here now and open up all the other great prospects of this company to a wider audience!! Cannot be long now until we get the news we have been waiting for. GLA

THE PROBLEM

Salt is the primary sodium ingredient used in processed food, and makes the greatest contribution to sodium intake in the United States. Too much sodium can raise blood pressure, which is a major risk factor for heart disease and stroke. As much as 70% of the average American’s salt intake comes from processed and restaurant foods, not salt added at the table.

Americans consume an average of 3,400mg of sodium per day – 50% more than the 2,300mg voluntary limit recommended by federal guidelines. Consequently, 1 in 3 US adults (70M) have high blood pressure and in the U.K., I in 4 adults have high blood pressure.

According to the FDA, reducing sodium intake by 33% will reduce an estimate of 28,000 to 50,000 premature deaths per year.

This is where Salarius will come into there own with Microsalt especially the way the world is today. I am sure it won’t be long until they enter this billion dollar market as mentioned they have the right people in place to make this happen!! Hopefully good news this week on Belluscura and FDA approval!! GLA

Totally agree Gheko regarding the report in the Times. Sadly though going by last weeks awful performance with no interest at all makes me think it’s not imminent otherwise the board would be buzzing too. But I hope I am wrong and a people do not get caught out . No matter what this is going to be a major company going forward with potential everywhere and feel comfortable invested short medium and long term. GLA our day is coming!!

Any sustained buying here and we will rise very quickly. Very welcome to see blue again!!

I know I keep saying that when the FDA announcement comes it comes but any news as to what stage it’s at would be welcome as we desperately need something to bring the excitement back here!

Calm before the storm, Waiting for the sea of blue!!

If there ever was a share where patience will be rewarded it’s this one. GLA

Again more positive sentiment regarding the company but yet we still are down and no interest at all! And this is also after the recent set of full year results to November 2019 - a period which saw record revenues and its net asset value increase by 40% to US$22.25m. Could do with the herd turning up now if only to get us over 20p as I keep saying the FDA announcement will happen when it happens.

I don’t think it matters if the seller has gone because for some unknown reason there is no interest today at all. As for FDA it will happen when it happens we all need to start concentrating on what other areas this company has to offer and how huge it will become.

Anyone have any ideas why the SP is reacting so poorly to what the majority of us see as an amazing RNS yesterday showing how financially sound the company is and how strong the portfolio is. More sells than buys over the 2 days and a 1% gain. Can really wind you up when you see other shares SP shooting up over 100% on nothing but hope.

Are you on a wind up?? This is probably the furthest away from a pump and dump you will ever get!! Best thing to do is look at the final results yesterday and also TEK,s portfolio

To be fair there are only a few shares that applies to and it’s not my favourite saying but I agree you wouldn’t want to be out of this share over the long weekend!! Onwards and upwards tomorrow.

Is anyone having problems buying?? Not a single buy for over an hour you don’t even get that on our dull days!! Hopefully finish over 20p today that’s the least I would of taken on the RNS. Very exciting times ahead.

Need to let the sellers do there thing and then let the buyers take charge. Anyone who has seen the RNS this morning would find it hard not to invest here or top up!!

Belluscura® (18.9% ownership) www.belluscura.com

· Continued progress with its patented portable oxygen concentrator programme
· Belluscura raised US $2.7m in 2019 at 15p/share to continue with its FDA clearance and go to market strategy equating to a post money valuation of ~US $9m.
· Belluscura anticipates receiving 510(K) clearance from the US FDA in H1 2020
· Post end of period, Belluscura filed an additional patent application covering devices and systems for treating people suffering from acute respiratory distress caused by the Coronavirus.

Net Assets increased 40% to US$22.25m, a record level (2018: US$16.13m)
· NAV per share US$0.35 (2018: US$0.30)
· Portfolio valuation increased 48% to US$20.3m (2018: US$13.70m)
· Total revenue US$7.72m (2018: US$6.83m)
- Revenue from services increased 15% to US$1.20m (2018: US$1.04m)
- Net increase of US$6.52m in fair value of portfolio companies (2018: US$5.79m)
· Profit before tax: US$5.52m (2018: US$4.55m)
· Reduction of operating expenses by 7% to US$1.59m (2018: US$1.72m).
· Service revenues cover approximately 55% of cost base (cost of sales and operating expenses)
· Placing to raise US$0.9m completed in July 2019.

Final results!! Looks amazing to me :)

A rise over 20p on the cards tomorrow. Obviously if there is news from the FDA we will be more like 30p+ . TEK,s time is coming!!

Could today be the day we finally find out about FDA approval??

Anything under 15p is such a bargain! On the dip this morning I managed to pick up some more. If we can get some buying pressure this will be back over 20p very quickly